These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1571712)

  • 21. Intensive chemotherapy versus allogeneic bone marrow transplantation in first-remission acute myeloid leukemia.
    Mayer RJ
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():48-51. PubMed ID: 2202467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute myelogenous leukemia with mediastinal and subcutaneous emphysema following chronic GVHD after allogeneic bone marrow transplantation].
    Doki N; Irisawa H; Saito Y; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2005 Sep; 46(9):1038-43. PubMed ID: 16440761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor leukocyte infusions for treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation.
    Forés R; Díez-Martin JL; Briz M; Cabrera JR; Sanjuán I; Regidor C; Garcia-Talavera J; Fernandez MN
    Bone Marrow Transplant; 1996 Mar; 17(3):439-41. PubMed ID: 8704703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T; Kojima S; Kato K
    Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
    Okano A; Shimazaki C; Ochiai N; Hatsuse M; Takahashi R; Ashihara E; Inaba T; Fujita N; Noda Y; Nakagawa M
    Bone Marrow Transplant; 2001 Oct; 28(7):709-11. PubMed ID: 11704796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic bone marrow transplantation from a related donor undergoing long-term immunosuppressive and cytotoxic therapy.
    Adams GB; Lipton JH; Jamal N; Messner HA
    Bone Marrow Transplant; 1994 Jun; 13(6):831-3. PubMed ID: 7920323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia.
    Tomonari A; Tojo A; Adachi D; Iseki T; Ooi J; Shirafuji N; Tani K; Asano S
    Ann Hematol; 2003 Jan; 82(1):37-40. PubMed ID: 12574963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Second marrow transplantation following high dose busulfan, etoposide, and Ara-C after testicular relapse in a patient with AML].
    Matsue K; Tohi T; Masauji N; Tsukuda K
    Rinsho Ketsueki; 1992 Mar; 33(3):338-42. PubMed ID: 1578638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term remission obtained by intensive chemotherapy against a leukemic relapse and subsequent graft-versus-host disease following an allogeneic BMT in a patient with myelodysplastic syndrome.
    Azuno Y; Kamei S; Kaku K; Yoshida T; Oeda E; Nishimura M; Okafuji K; Takeuchi Y; Tanaka M; Oka Y; Hiroshige Y; Kaneko T
    Bone Marrow Transplant; 1996 Mar; 17(3):463-4. PubMed ID: 8704709
    [No Abstract]   [Full Text] [Related]  

  • 34. [Allogeneic bone marrow transplantation in a case of acute lymphoblastic leukemia with positive Philadelphia chromosome].
    Kitoh T; Tabata Y; Akiyama Y; Kiriyama Y; Kubota M; Mikawa H
    Rinsho Ketsueki; 1989 May; 30(5):680-5. PubMed ID: 2795882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Durable remission of Sézary syndrome after unrelated bone marrow transplantation by reduced-intensity conditioning.
    Kahata K; Hashino S; Takahata M; Fujisawa F; Kondo T; Kobayashi S; Fujita Y; Shimizu H; Imamura M; Asaka M
    Acta Haematol; 2008; 120(1):14-8. PubMed ID: 18716396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
    Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
    Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic BMT for AML in Zagreb.
    Labar B; Bogdanić V; Nemet D; Mrsić M; Pavletić Z; Zupancić S; Radman I; Aurer I
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():86-7. PubMed ID: 2697413
    [No Abstract]   [Full Text] [Related]  

  • 38. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
    Galimberti M; Polchi P; Lucarelli G; Angelucci E; Baronciani D; Giardini C; Gaziev D; Erer B; Ripalti M; Rapa S
    Bone Marrow Transplant; 1994 Feb; 13(2):197-201. PubMed ID: 8205089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
    Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
    Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
    Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.